Not sure when the partner will come into the picture, either pre or post approval. But I agree that, weirdly enough, given the idiotic marketing strategy of Braeburn, Europe could be bigger than the US. It will be priced low, because the European partner is basically just marketing it, and the European countries negotiate cheaper prices for drugs.
Given Braeburn's crazy price tag, it would be cheaper for insurance companies to buy people a ticket to Europe to get the implant than get it in the US!
News 
Market Data 
Discover 
AI
